Tag: melanoma
3 predictions tagged with "melanoma".
Personalized MRNA Cancer Vaccines Are Expected To Show Promising Phase 3 Trial Results.2027 · Health
Moderna And Merck's Personalized MRNA Neoantigen Cancer Vaccine Intismeran Autogene (V940/mRNA-4157) Is Expected To Receive Its First Regulatory Approval In 2028 As Adjuvant Treatment For High-risk Melanoma.2028 · Health
Personalized MRNA Cancer Vaccines Will Gain Approval Or Enter Standard Adjuvant Care In At Least Two Cancer Types Beyond Melanoma (Lung And Pancreatic).2035 · Health
